Figure EV7. T172 phosphorylation of BCL9 is selected enriched and interacted in tumours, and its expression is correlated with cancer patients' prognosis (related to Fig 7).
- Immunohistochemical staining of P‐T172‐BCL9 or CDK1 on two sequential HCC slides from one patient. The red arrows indicate the protein expression in the same tumour cells. Scale bars represent 100 μm.
- Pearson correlation analysis of the expression of P‐T172‐BCL9 and c‐Myc in 145 breast cancer patients by immunohistochemical staining.